Safe & Secure
WHAT IS THE SELPHYL® PRFM SYSTEM?
The SELPHYL® System is designed for the safe and rapid preparation of Platelet-rich Fibrin Matrix (PRFM) from a small sample of blood at the patient point of care. Many PRP systems require operator skill, have varying results and have extensive contamination with red blood cells and white blood cells. SELPHYL® removes virtually all contaminating cells and is independent of operator technique. PRP is converted to PRFM through a controlled process, creating a scaffold that serves to protect and preserve platelets.
Think of SELPHYL® PRFM as the next generation PRP.
The Power of Platelets
Platelets and other components in human blood migrate to a site of injury. Platelets are known to release a variety of growth factors that respond to tissue injury, where they initiate and promote healing. By concentrating platelets at the site of injury, physicians have the potential to enhance the body’s natural capacity for healing.
The Key Advantages & Benefits
VISUAL GUIDE TO QUALITY
COMPLETELY CLOSED SYSTEM
FIBRIN MATRIX SCAFFOLD
SUSTAINED PLATELET GROWTH FACTOR RELEASE FOR DAYS
EXTENSIVE SAFETY PROFILE
OVER 150K PATIENTS TREATED
NEXT GENERATION PRP
WHAT IS PLATELET-RICH PLASMA (PRP)?
PRP, by definition refers to platelets in plasma, where the platelet concentration is generally considered to be twice the normal concentration in whole blood. Nowhere in the definition of PRP is there a description for including red blood cells (RBC) or white blood cells (WBC) – in fact, these cells should be removed as much as possible from a PRP preparation. Some kits that tout high platelet concentrations often do so at the expense of having contaminating RBCs or WBCs – these cells are known to have inflammatory and catabolic effects – just the opposite of the desired effect. If the PRP in the syringe has any tinge of pink or red, it is mostly likely that you are injecting a preparation that has RBC contamination.
The ideal PRP solution will be a golden, straw-like color.
PRP vs. PRFM
Platelets in plasma
Activation is immediate
Alpha granules release growth factors quickly (bolus)
Short-term tissue signaling
Minutes – hours
Platelets in fibrin matrix
CaCl2 binds to Na Citrate 1:1
Clotting cascade resumes (Fibrinogen – Fibrin)
Platelets remain viable with controlled GF release
Hours – days
Become a Provider
Discover the transformative power of our PRFM technology and experience the future of platelet therapy. Contact us today to become a provider and learn more about how Selphyl can elevate your practice and enhance patient care.
WHAT IS THE REGULATORY STATUS OF THE SELPHYL® SYSTEM?
The SELPHYL® System was cleared for marketing in 510(k) premarket notification number BK170096. Factor Medical, Inc. markets the Autologous Fibrin & Platelet System in this 510(k) under the trade names SELPHYL® and PRFM.
CAUTION: United States Federal law restricts this device to sale and distribution by or on the order of a physician, or to a clinical laboratory; and use is restricted to, by or on the order of a physician.
SIGN UP for our newsletter to receive important updates and monthly promotions!